The severity of PLN-R14del-associated cardiomyopathy is evidenced by mutation carriers having higher incidences of malignant arrhythmias, premature sudden cardiac death (SCD) and cardiac transplantation, as compared to DCM and ARVC patients that do not carry this pathogenic variant9. Here, PLN is linked to cardiomyopathy.